Attorney Advertising  ·  The Alvarez Law Firm  ·  Coral Gables, FL

This lawsuit is actively accepting new filers. Check if you qualify — free, 2 minutes.
LAWSUIT
Loop
See If You Qualify
Open Pharma

People Who Took Zantac for Years May Be Owed Money After Cancer-Causing Chemical Found

Millions of people took Zantac (ranitidine) daily for heartburn. Then scientists discovered the drug itself can produce a probable cancer-causing chemical. State court cases are now being filed.

By the Lawsuit Loop Editorial Team · Reviewed by TALF Legal · Published Apr 13, 2026 · 6 min read · Updated weekly
Stock image — not an actual client
Free Case Check · 2 Minutes Private · No fee unless you win

See if you qualify for this lawsuit

Quick form — a real person will review your info and reach out if you may have a case.

Zantac (ranitidine) was one of the best-selling heartburn drugs in the world. Millions of people took it daily for years. Then, in 2019, scientists discovered that ranitidine itself can degrade into a chemical called NDMA — a probable human carcinogen — especially when stored at room temperature or exposed to heat.

In April 2020, the FDA pulled all ranitidine products from the market. Lawsuits allege that manufacturers including Sanofi, Pfizer, Boehringer Ingelheim, and GlaxoSmithKline knew — or should have known — about the NDMA risk and failed to warn consumers.

While a large federal case was dismissed in 2022, state court cases in Delaware, California, and elsewhere remain active and are being filed. If you took Zantac regularly and were later diagnosed with cancer, take two minutes to check if you qualify.

What the Zantac Lawsuit Is About

NDMA (N-nitrosodimethylamine) is a chemical classified as a probable human carcinogen by the FDA and the International Agency for Research on Cancer (IARC).1,3 It is found in small amounts in some foods, but at high levels, it has been shown to cause cancer in animal studies.

What makes ranitidine unusual is that the NDMA doesn't come from contamination — the drug itself can produce NDMA as it breaks down. A 2023 study published in JAMA found that ranitidine's instability meant people who took it were potentially exposed to significantly elevated levels of NDMA over time, particularly if they took the drug regularly for months or years and stored it at typical home temperatures.2

The FDA's April 2020 market withdrawal was unprecedented — it was not a recall, but a complete removal of ranitidine from the U.S. market.1

Who May Qualify

You may qualify if both of the following apply:

  1. You took Zantac (ranitidine) or a generic ranitidine product on a regular basis — typically for a year or more.
  2. You were later diagnosed with bladder cancer, stomach cancer, colorectal cancer, liver cancer, esophageal cancer, pancreatic cancer, or another qualifying cancer.
Think You May Qualify?

Takes two minutes — fill out the free form below to find out.

Tell us how long you took Zantac and what your diagnosis was. A real person will review your information and reach out if you may have a case.

Start Free Case Check →

What Could This Mean for You?

If you qualify, you may be owed money for medical bills, lost wages, and pain and suffering connected to your cancer diagnosis. State court cases are actively being filed and evaluated on an individual basis.

We will not quote you a specific number. What any case may be worth depends entirely on your individual diagnosis, the severity of your treatment, your medical history, and how your case resolves. Anyone who gives you a specific dollar figure at this stage is guessing — and we won't do that.

What we can say: checking if you qualify is free, takes two minutes, and you pay nothing out of pocket unless your case wins.

Filing Deadline

Every state has a law called a statute of limitations — a deadline for filing. In cancer cases, the clock often starts when you knew or should have known about the possible connection between the drug and your diagnosis.

Because the federal MDL was dismissed in 2022, many people are now pursuing state court cases instead — and deadlines in some states may be approaching. The single biggest reason not to wait is that once the deadline passes, you cannot file — even if you clearly would have qualified.

Free Case Check · Secure Intake No fee unless you win

How the Process Works

Step 1 — Fill out the free form

No cost, no commitment. Takes about two minutes. A real person on our intake team reviews every submission.

Step 2 — A lawyer's team reviews your case

They look at your Zantac use and medical history. If it looks like you may qualify, someone reaches out to you. If you don't hear back within a week, please contact another firm before your state's deadline passes.

Step 3 — You pay nothing unless you win

Attorneys work on contingency — that means no out-of-pocket fees. If your case doesn't recover money, you owe nothing. Ever.

Step 4 — Your case is filed

Your case is filed in the appropriate state court. You are kept updated. Most people never have to travel or appear in a courtroom.

Common Questions

I took generic ranitidine, not brand-name Zantac — does this apply?
Yes. All ranitidine products — branded and generic — were pulled from the market for the same NDMA reason. The issue is with the ranitidine molecule itself, not just Zantac specifically.
The federal MDL was thrown out — does that mean cases are over?
No. State court cases are actively proceeding in Delaware, California, and elsewhere. The federal dismissal does not affect state cases.
What if I stopped taking Zantac years ago?
You may still qualify. Cancer linked to NDMA exposure can develop years after the exposure itself. The time between exposure and diagnosis can be significant.
Do I need old pharmacy records?
Helpful but not required to get started. Many people remember taking Zantac without keeping old receipts or boxes. A lawyer's team can help piece together the history.
What if I took it occasionally, not every day?
Regular, long-term use is the key factor. How often and for how long you took ranitidine matters — but you don't need to have taken it every single day.

Sources

  • 1 FDA Drug Safety Communication: "FDA Updates and Press Announcements on NDMA in Zantac (ranitidine)," April 2020. U.S. Food & Drug Administration.
  • 2 Emery, C. et al. "NDMA in Ranitidine." JAMA, 2023.
  • 3 International Agency for Research on Cancer. IARC Monographs Volume 116: N-Nitrosodimethylamine. World Health Organization.
Start Your Free Case Check

Find out if you qualify — right now

Fill out the form below. A real person reviews every submission and will reach out within one week if you may have a case.

Private & secure

Reviewed only by our team. Never sold.

No fee unless you win

You pay nothing out of pocket. Ever.

Reply within one week

If you don't hear back, please contact another firm before the deadline.

Don't wait — deadlines apply

Every case has a filing window. Sooner is better.

Secure Intake Form 2 minutes · Free

Related Lawsuits

See If You Qualify See If You Qualify — Free